Loading grant details…
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
| Funder | National Institutes of Health |
|---|---|
| Recipient Organization | Not specified |
| Country | USA |
| Start Date | Oct 02, 2024 |
| End Date | Jan 20, 2029 |
| Duration | 1,571 days |
| Number of Grantees | 1 |
| Data Source | Grants.gov |
| Grant ID | 5394c2b0-5d9d-4482-9485-8126ea03ec94 |
Grant Description
The purpose of this Program Announcement (PAR) is to enable clinical validation of strong candidate biomarkers for neurological diseases and conditions.
Specifically, the goal of this PAR is to enable the rigorous validation of biomarker measurements within the clinical population of interest to establish the positive and negative predictive values of the candidate biomarker consistent with FDA guidelines.
This PAR assumes that 1) a candidate biomarker has already been identified, 2) detection method technology has already been developed and analytically validated, and 3) the research and/or clinical need and potential context of use has been identified.
All Grantees
To be determined
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Related Grants
